apoC-II Antibodies

Santa Cruz Biotechnology delivers a wide array of apoC-II monoclonal antibodies for advanced research in lipid metabolism and cardiovascular health. apoC-II Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein C-II (apoC-II) plays a crucial role in lipid transport and metabolism, acting as a cofactor for lipoprotein lipase, which is essential for the hydrolysis of triglycerides in lipoproteins. Its proper functioning is vital for maintaining lipid homeostasis and preventing dyslipidemia, which can lead to cardiovascular diseases. Understanding apoC-II's role in metabolic processes helps advance therapeutic strategies for managing lipid-related disorders. Researchers can investigate specific molecular pathways involved in lipid metabolism using apoC-II monoclonal antibodies. The high specificity of apoC-II monoclonal antibodies enables precise detection and analysis of target proteins in complex biological samples. Detailed characterization of apoC-II expression patterns and interactions provides valuable insights into cardiovascular disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of lipid metabolism and cardiovascular health.